Literature DB >> 7651690

Compliance in patients prescribed eyedrops for glaucoma.

S C Patel1, G L Spaeth.   

Abstract

We studied the rate of failure to use eyedrops as prescribed for glaucoma and some of the factors possibly associated with that noncompliance by interviewing 100 patients being followed in a setting emphasizing correct usage. Fifty-nine reported they had not used their eyedrops precisely as prescribed. Factors significantly influencing compliance included daily dose frequency, forgetfulness, inconvenience, and unaffordability. Gender and race were marginally significant factors, with men and blacks reporting somewhat higher rates of missed doses than women and whites. Side effects and age were not significant causes of noncompliance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651690

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  93 in total

1.  Patients prefer once-daily glaucoma drops.

Authors:  Alex J Buller; Laurence H Morgan; Brian L Hercules
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

2.  A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe.

Authors:  J García-Sánchez; J-F Rouland; D Spiegel; B Pajic; I Cunliffe; C Traverso; J Landry
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

3.  The influence of health literacy level on an educational intervention to improve glaucoma medication adherence.

Authors:  Kelly W Muir; Alice Ventura; Sandra S Stinnett; Abraham Enfiedjian; R Rand Allingham; Paul P Lee
Journal:  Patient Educ Couns       Date:  2011-10-13

4.  Accuracy and performance of a commercially available Dosing Aid.

Authors:  Tara H Cronin; Malik Y Kahook; Kira L Lathrop; Robert J Noecker
Journal:  Br J Ophthalmol       Date:  2006-08-17       Impact factor: 4.638

5.  Patient attitudes toward novel glaucoma drug delivery approaches.

Authors:  Benjamin B Wang; Michael M Lin; Thuan Nguyen; Angela V Turalba
Journal:  Digit J Ophthalmol       Date:  2018-09-30

6.  Microprocessor controlled compliance monitor for eye drop medication.

Authors:  M M Hermann; M Diestelhorst
Journal:  Br J Ophthalmol       Date:  2006-03-15       Impact factor: 4.638

Review 7.  Evolving paradigms in the medical treatment of glaucoma.

Authors:  John S Cohen; Anup K Khatana; Linda J Greff
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

8.  Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.

Authors:  Christine M G Olthoff; Juliette G M M Hoevenaars; Bart W van den Borne; Carroll A B Webers; Jan S A G Schouten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-19       Impact factor: 3.117

9.  Improving Access to Eye Care among Persons at High-Risk of Glaucoma in Philadelphia--Design and Methodology: The Philadelphia Glaucoma Detection and Treatment Project.

Authors:  Lisa Hark; Michael Waisbourd; Jonathan S Myers; Jeffrey Henderer; John E Crews; Jinan B Saaddine; Jeanne Molineaux; Deiana Johnson; Harjeet Sembhi; Shayla Stratford; Ayman Suleiman; Laura Pizzi; George L Spaeth; L Jay Katz
Journal:  Ophthalmic Epidemiol       Date:  2016-03-07       Impact factor: 1.648

10.  Noncompliance with glaucoma medication in Korean patients: a multicenter qualitative study.

Authors:  Myoung Hee Park; Kyu-Dong Kang; Jungil Moon
Journal:  Jpn J Ophthalmol       Date:  2012-10-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.